<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">healthcare</journal-id><journal-title-group><journal-title xml:lang="ru">Здравоохранение. Healthcare</journal-title><trans-title-group xml:lang="en"><trans-title>Healthcare</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1027-7218</issn><publisher><publisher-name>Republican Scientific and Practical Center for Medical Technologies, Informatization, Management and Health Economics</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.65249/1027-7218-2026-6-44-50</article-id><article-id custom-type="elpub" pub-id-type="custom">healthcare-308</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЩЕСТВЕННОЕ ЗДОРОВЬЕ И ЗДРАВООХРАНЕНИЕ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>PUBLIC HEALTH AND HEALTHCARE</subject></subj-group></article-categories><title-group><article-title>Алгоритм расчета индекса лекарственной устойчивости: методология и практическое применение</article-title><trans-title-group xml:lang="en"><trans-title>Drug resistance index calculation algorithm: methodology and practical application</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7538-8236</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Малинка</surname><given-names>Т. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Malinka</surname><given-names>T.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Малинка Тамара Валерьевна – врач – клинический фармаколог</p><p>Агр. Ждановичи, 81/5, 223052, Минский р-н Сл. тел. + 375 17 543-43-59</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0960-7784</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Хейфец</surname><given-names>Н. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Kheifets</surname><given-names>N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Хейфец Николай Ефимович</p><p>Минск</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4717-5249</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кожанова</surname><given-names>И. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Kozhanova</surname><given-names>I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кожанова Ирина Николаевна</p><p>Минск</p></bio><xref ref-type="aff" rid="aff-3"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>Республиканский клинический медицинский центр Управления делами Президента Республики Беларусь</institution><country>Belarus</country></aff><aff xml:lang="ru" id="aff-2"><institution>Республиканский научно-практический центр медицинских технологий, информатизации, управления и экономики здравоохранения</institution><country>Belarus</country></aff><aff xml:lang="ru" id="aff-3"><institution>Белорусский государственный медицинский университет</institution><country>Belarus</country></aff><pub-date pub-type="collection"><year>2026</year></pub-date><pub-date pub-type="epub"><day>01</day><month>08</month><year>2026</year></pub-date><volume>0</volume><issue>6</issue><fpage>44</fpage><lpage>50</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Малинка Т.В., Хейфец Н.Е., Кожанова И.Н., 2026</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="ru">Малинка Т.В., Хейфец Н.Е., Кожанова И.Н.</copyright-holder><copyright-holder xml:lang="en">Malinka T., Kheifets N., Kozhanova I.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://healthcare.ejournal.by/jour/article/view/308">https://healthcare.ejournal.by/jour/article/view/308</self-uri><abstract><p>Цель исследования. Адаптировать методику расчета индекса лекарственной устойчивости с учетом доступных в Республике Беларусь электронных баз данных и инструментов анализа потребления лекарственных препаратов, составить инструкцию с детальным изложением последовательности этапов, необходимых для корректного применения методики.Материал и методы. Исследование носит методологический характер. В основу работы положена методика расчета интегрального индекса лекарственной устойчивости. В качестве источника исходных данных рассматривается программное обеспечение WHONET, используемое для формирования выборок по микроорганизмам и их чувствительности к антимикробным препаратам. Для иллюстрации метода использован демонстрационный пример на модельных данных.Результаты. Представлена пошаговая схема расчета индекса лекарственной устойчивости, включающая формализацию всех этапов обработки данных и агрегирования показателей. Демонстрационный пример иллюстрирует последовательность расчета и особенности интерпретации итогового значения индекса.Заключение. Предложенный подход обеспечивает прозрачность и воспроизводимость расчета интегрального индекса лекарственной устойчивости и может быть использован для стандартизации анализа данных. Детализация методики способствует ее внедрению в научную и практическую деятельность, объективизирует ее в качестве инструмента принятия управленческих решений в области управления антибактериальной терапией.</p></abstract><trans-abstract xml:lang="en"><p>Objective. To adapt the drug resistance index calculation methodology to electronic databases and drug consumption analysis tools available in the Republic of Belarus and to develop instructions detailing the sequence of steps required for the correct application of the methodology.Materials and methods. This study is methodological. It is based on a methodology for calculating the integrated drug resistance index. WHONET software, used to generate samples of microorganisms and their susceptibility to antimicrobials, is considered as the source of initial data. A demonstration example using simulated data is used to illustrate the method.Results. A step-by-step process for calculating the drug resistance index is presented, including formalization of all stages of data processing and indicator aggregation. The demonstration example illustrates the calculation sequence and the specifics of interpreting the final index value.Conclusion. Proposed approach ensures transparency and reproducibility in calculating the integrated drug resistance index and can be used to standardize data analysis. Detailed methodology facilitates its implementation in scientific and practical activities, objectifying it as a tool for making management decisions in the field of antibacterial therapy management.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>методология</kwd><kwd>индекс лекарственной устойчивости</kwd><kwd>управление антибиотикотерапией</kwd></kwd-group><kwd-group xml:lang="en"><kwd>methodology</kwd><kwd>drug resistance index</kwd><kwd>antibiotic therapy management</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Assessing effectiveness of antibiotic therapy against gram-negative bacteria in a saudi hospital using a drug resistance index / M. Yaseen, A. Al-Thaqafi, M. Alshamrani [et al.] // Infection Control and Hospital Epidemiology. – 2020. – Vol. 41. – doi: 10.1017/ice.2020.640.</mixed-citation><mixed-citation xml:lang="en">Yaseen M., Al-Thaqafi A., Alshamrani M., et al. Assessing effectiveness of antibiotic therapy against gram-negative bacteria in a saudi hospital using a drug resistance index. Infect Control Hosp Epidemiol. 2020. 41. doi: 10.1017/ice.2020.640.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Measurement and prediction of antimicrobial resistance in bloodstream infections by ESKAPE pathogens and Escherichia coli / G. V. D. Socio, P. Rubbioni, D. Botta [et al.] // Journal of Global Antimicrobial Resistance. – 2019. – Vol. 19. – P. 154–160.</mixed-citation><mixed-citation xml:lang="en">Socio G. V. D., Rubbioni P., Botta D., et al. Measurement and prediction of antimicrobial resistance in bloodstream infections by ESKAPE pathogens and Escherichia coli. J Glob Antimicrob Resist. 2019; 19: 154–160.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Протоколы по обеспечению безопасности пациентов в многопрофильном стационаре : учеб.-метод. пособие / Е. Б. Клейменова, Л. П. Яшина, С. А. Пающик В. А. Отделенов ; под ред. акад. Д. А. Сычева, проф. А. В. Самойловой . – 2-е изд., перераб. – М. : Медконгресс, 2025. – 496 с.</mixed-citation><mixed-citation xml:lang="en">Klejmenova E.B., Yashina L.P., Payushchik S.A., Otdelenov V.A. Protocols for ensuring patient safety in a multidisciplinary hospital. Moscow: Medkongress; 2025. 496. (in Russian)</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Guidelines for ATC classification and DDD assignment / WHO Collaborating Centre for Drug Statistics Methodology. – 2018. – URL: https://www.drugsandalcohol.ie/29364/1/WHO%20Collaborating%20Centre%20for%20Drug%20Statistics%20Methodology.pdf (date of access: 20.04.2026).</mixed-citation><mixed-citation xml:lang="en">WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment, 2018. Available at: https://www.drugsandalcohol.ie/29364/1/WHO%20Collaborating%20Centre%20for%20Drug%20Statistics%20Methodology.pdf (accessed: 20.04.2026).</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Карноух, К. И. Индекс лекарственной устойчивости как критерий эффективности внедрения стратегии контроля антимикробной терапии / К. И. Карноух, Е. В. Ших, Н. Б. Лазарева // Клиническая фармакология и терапия. – 2022. – T. 31, № 3. – С. 67–73.</mixed-citation><mixed-citation xml:lang="en">Karnouh K.I., Shih E.V., Lazareva N.B. The drug resistance index as a criterion for the effectiveness of the implementation of the antimicrobial therapy control strategy. Klinicheskaya farmakologiya i terapiya. 2022; 31(3): 67–73. (in Russian)</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Tracking global trends in the effectiveness of antibiotic therapy using the Drug Resistance Index / E. Y. Klein, K. K. Tseng, S. Pant, R. Laxminarayan // BMJ Global Health. – 2019. – Vol. 4, № 2. – doi: 10.1136/BMJGH-2018-001315.</mixed-citation><mixed-citation xml:lang="en">Klein E.Y., Tseng K.K., Pant S., Laxminarayan R. Tracking global trends in the effectiveness of antibiotic therapy using the Drug Resistance Index. BMJ Glob Health. 2019; 4(2). doi: 10.1136/BMJGH-2018-001315.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Using an index-based approach to assess the population-level appropriateness of empirical antibiotic therapy / M. Ciccolini, V. Spoorenberg, S. E. Geerlings [et al.] // Journal of Antimicrobial Chemotherapy. – 2015. – Vol. 70, № 1. – P. 286–293.</mixed-citation><mixed-citation xml:lang="en">Ciccolini M., Spoorenberg V., Geerlings S.E., et al. Using an index-based approach to assess the population-level appropriateness of empirical antibiotic therapy. J Antimicrob Chemother. 2015; 70(1): 286–293.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Laxminarayan, R. Communicating trends in resistance using a drug resistance index / R. Laxminarayan, K. P. Klugman // BMJ Open. – 2011. – Vol. 1, № 2. – doi: 10.1136/BMJOPEN-2011-000135.</mixed-citation><mixed-citation xml:lang="en">Laxminarayan R., Klugman K.P. Communicating trends in resistance using a drug resistance index. BMJ Open. 2011. 1(2). doi: 10.1136/BMJOPEN-2011-000135.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
